2022 2021/  2020 /  2019 /  2018 / 2017 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008
06.23.2022- Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases

Astrotech Corporation (Nasdaq: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus.

05.12.2022- Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.

02.11.2022- Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.

02.02.2022- Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as its Chief Science Officer

 Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.

01.06.2022- Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder proposals

Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the “2021 Annual Meeting”) on Friday, March 25, 2022. The 2021 Annual Meeting will be held at 9:00 A.M. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the AT&T Hotel and Conference Center.